These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mice harboring pathobiont-free microbiota do not develop intestinal inflammation that normally results from an innate immune deficiency. Chassaing B; Gewirtz AT PLoS One; 2018; 13(4):e0195310. PubMed ID: 29617463 [TBL] [Abstract][Full Text] [Related]
6. TLR5 is not required for flagellin-mediated exacerbation of DSS colitis. Ivison SM; Himmel ME; Hardenberg G; Wark PA; Kifayet A; Levings MK; Steiner TS Inflamm Bowel Dis; 2010 Mar; 16(3):401-9. PubMed ID: 19774646 [TBL] [Abstract][Full Text] [Related]
7. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease. Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809 [TBL] [Abstract][Full Text] [Related]
8. Genetically engineered Bifidobacterium animalis expressing the Salmonella flagellin gene for the mucosal immunization in a mouse model. Takata T; Shirakawa T; Kawasaki Y; Kinoshita S; Gotoh A; Kano Y; Kawabata M J Gene Med; 2006 Nov; 8(11):1341-6. PubMed ID: 16958059 [TBL] [Abstract][Full Text] [Related]
9. Antibody responses against flagellin in mice orally immunized with attenuated Salmonella vaccine strains. De Almeida ME; Newton SM; Ferreira LC Arch Microbiol; 1999 Aug; 172(2):102-8. PubMed ID: 10415171 [TBL] [Abstract][Full Text] [Related]
10. Vaccination against microbiota motility protects mice from the detrimental impact of dietary emulsifier consumption. Kordahi MC; Delaroque C; Bredèche MF; Gewirtz AT; Chassaing B PLoS Biol; 2023 Sep; 21(9):e3002289. PubMed ID: 37725584 [TBL] [Abstract][Full Text] [Related]
11. Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery. Scheithauer TPM; Davids M; Winkelmeijer M; Verdoes X; Aydin Ö; de Brauw M; van de Laar A; Meijnikman AS; Gerdes VEA; van Raalte D; Herrema H; Nieuwdorp M Gut Microbes; 2022; 14(1):2031696. PubMed ID: 35130127 [TBL] [Abstract][Full Text] [Related]
12. Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation. Lima SF; Gogokhia L; Viladomiu M; Chou L; Putzel G; Jin WB; Pires S; Guo CJ; Gerardin Y; Crawford CV; Jacob V; Scherl E; Brown SE; Hambor J; Longman RS Gastroenterology; 2022 Jan; 162(1):166-178. PubMed ID: 34606847 [TBL] [Abstract][Full Text] [Related]
13. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis. Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078 [TBL] [Abstract][Full Text] [Related]
14. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cullender TC; Chassaing B; Janzon A; Kumar K; Muller CE; Werner JJ; Angenent LT; Bell ME; Hay AG; Peterson DA; Walter J; Vijay-Kumar M; Gewirtz AT; Ley RE Cell Host Microbe; 2013 Nov; 14(5):571-81. PubMed ID: 24237702 [TBL] [Abstract][Full Text] [Related]
15. Vaccine therapy for dysbiosis-related diseases. Fujimoto K; Uematsu S World J Gastroenterol; 2020 Jun; 26(21):2758-2767. PubMed ID: 32550752 [TBL] [Abstract][Full Text] [Related]